Table 1

Literature review of Posttransplant lymphoproliferative disorders (PTLD) arsing in the oral cavity

Author

Age & sex, site

Onset

Diagnosis, site

EBV status

Treatment

Follow up


Doak et al 1968

34 ♂, kidney

180 days

Reticular Cell Sarcoma, tongue & oral cavity

Viral inclusions

Antimycotic Medication NOS

Died 30 days after

Staddlemann et al 1996

65 ♀, kidney

600 days

NK/T-cell lymphoma, pharynx

Positive

Cyclosporine d/c, Four cycles CHOP

Remission for 1080 days

Reams et al 2003

16 ♀, R + L lung

330 days

Polymorphic B-cell lymphoma, tongue

Negative

Four cycles of Rituximab

Patient died of Sepsis

Rolland et al 2004

60 ♂, heart

3600 days

Peripheral T-cell lymphoma NOS, gingiva

Positive

Azathioprine d/c, decrease Cyclosporin

Remission for 360 days

Rolland et al 2004

61 ♂, heart

1410 days

DLBCL, maxilla

Posotive

Stepwise decrease in Ciclosporin

Recurrences at 180 and 510 days

Bruce et al 2006

45 ♀, pancreas

660 days

DLBCL, tongue

Positive

Sirolimus d/c Tacrolimus adjusted

Remission 660 days, AR

Gonzalez-Cuyar et al 2007

47, ♂, kidney pancreas

720 days

DLBCL, tongue

Positive

Decreased immunosupression

Remission for 790 days


Gonzalez-Cuyar et al. Diagnostic Pathology 2007 2:49   doi:10.1186/1746-1596-2-49

Open Data